Table 2.

Distribution characteristics of patients by death and person-time

	TB group (N=77)		Non-TB group (N=308)		P value for the absolute difference in death rate
Variable	Total person-months	No. Deaths	Total person-months	No. Deaths
Overall	1333.27	11	7801.57	21	0.002
Age
18–<30	508.70	5	2884.00	4	0.001
30–<40	564.53	3	3116.77	9	0.353
40–<50	178.07	3	1561.43	7	0.039
50–70	81.97	0	239.37	1	0.558
Gender
Females	962.23	8	5960.53	12	0.001
Males	371.03	3	1841.03	9	0.446
Marital status
Married or cohabiting	493.00	4	4983.83	9	0.006
Single	840.27	7	2817.73	12	0.151
Source of referral
Any Muhimbili clinic	136.20	0	646.80	2	0.516
Infectious Diseases Centre	97.57	1	544.40	0	-
NGO VCT	693.33	7	4232.37	10	0.001
Self referred	178.20	1	726.73	4	0.986
Other	229.97	2	1651.26	5	0.187
CD4 count at or around the matching time
<200	790.13	7	4896.53	11	0.002
200–<250	108.43	2	680.77	4	0.163
250–<300	178.13	0	777.83	4	0.339
300–<350	92.77	0	497.70	1	0.666
≥350–2000	163.80	2	948.73	1	0.010
On ART at matching
On medication	104.10	0	428.47	2	0.486
Not on medication	1229.17	11	7373.10	19	<0.001
On ART at some point during follow-up
On medication	157.03	0	428.47	2	0.392
Not on medication	1176.23	11	7373.10	19	<0.001
Vaccine arm
M. vaccae	450.97	7	3824.87	9	<0.001
Placebo	882.30	4	3966.7	12	0.481
Isoniazid preventive therapy (at DarDar baseline)
Not eligible for therapy	845.67	6	5431.27	15	0.043
Eligible, not adhered	116.37	4	254.63	2	0.062
Eligible, adhered	371.23	1	2115.67	4	0.003
On co-trimoxazole during matching
On medication	506.80	6	1550.70	5	0.021
Not on medication	826.47	5	6250.87	16	0.083
On co-trimoxazole at some point during follow-up
On medication	1227.37	10	3562.83	8	0.004
Not on medication	105.90	1	4238.73	13	0.254